7 agosto 2015
A new test allows physicians to measure the effects of gene silencing therapy in Huntington’s disease and will support the first human clinical trial of a drug that targets the genetic cause of the disease.
http://www.sciencedaily.com/releases/2015/08/150807110744.htm
